Lilly - NUS (Singapore)
Lilly: Answers That Matter.
homeabout usresearch interestscareersvolunteerscontact us
Lilly - NUS Research Interests


Overview  |  Endocrine Disorders  |  Infectious Diseases  |  Neuroscience  |  Cardiovascular Diseases  |  Drug Metabolism / Miscellaneous


Drug Metabolism / Miscellaneous

  1. CYP3A activity as determined by midazolam PK, is similar between Chinese, Indians and Caucasians before and after rifampicin treatment but not as determined by 6b-OH cortisol formation. American Society for Clinical Pharmacology and Therapeutics Annual Meeting 2003, Washington D.C.

  2. ALT, GGT and White Cell Count are related to body mass, but also to ethnic origin. National University Hospital, Annual Scientific Meeting 2001

  3. Preliminary Report on the CYP2D6 Genotype in the Singapore Population. 2nd Asian Clinical Trials Conference, Singapore, October 1999

  4. A review and assessment of potential sources of ethnic differences in drug responsiveness. J Clin Pharmacol. 2003 Sep;43(9):943-67. Review

  5. Quinidine does not affect the renal clearance of moxonidine. Br J Clin Pharmacol. 2002 Sep;54(3):251-4

  6. Clinical drug development--practical issues in clinical pharmacology studies. Ann Acad Med Singapore. 2000 Sep;29(5):582-7


We'd like to tell you more about our company and the work we do.
 
Copyright © 2005 Eli Lilly and Company. All rights reserved.       Site Map